A detailed history of Assetmark, Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Assetmark, Inc holds 33,888 shares of BDX stock, worth $7.69 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
33,888
Previous 31,684 6.96%
Holding current value
$7.69 Million
Previous $7.4 Million 10.35%
% of portfolio
0.02%
Previous 0.02%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$221.47 - $242.41 $488,119 - $534,271
2,204 Added 6.96%
33,888 $8.17 Million
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $157,098 - $171,826
698 Added 2.25%
31,684 $7.4 Million
Q1 2024

May 06, 2024

BUY
$233.45 - $247.73 $344,338 - $365,401
1,475 Added 5.0%
30,986 $7.67 Million
Q4 2023

Feb 09, 2024

BUY
$232.24 - $267.23 $301,215 - $346,597
1,297 Added 4.6%
29,511 $7.2 Million
Q3 2023

Oct 27, 2023

BUY
$254.9 - $283.59 $1.1 Million - $1.22 Million
4,315 Added 18.06%
28,214 $7.29 Million
Q2 2023

Aug 11, 2023

BUY
$238.39 - $265.32 $724,228 - $806,042
3,038 Added 14.56%
23,899 $6.31 Million
Q1 2023

May 05, 2023

BUY
$229.71 - $259.35 $571,977 - $645,781
2,490 Added 13.55%
20,861 $5.16 Million
Q4 2022

Feb 10, 2023

BUY
$218.29 - $256.91 $884,074 - $1.04 Million
4,050 Added 28.28%
18,371 $4.67 Million
Q3 2022

Nov 01, 2022

BUY
$51.03 - $264.23 $152,630 - $790,311
2,991 Added 26.4%
14,321 $3.19 Million
Q2 2022

Aug 03, 2022

BUY
$234.74 - $275.42 $1.31 Million - $1.54 Million
5,596 Added 97.59%
11,330 $2.79 Million
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $1.04 Million - $1.15 Million
4,262 Added 289.54%
5,734 $1.53 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $176,471 - $192,470
767 Added 108.79%
1,472 $370,000
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $7,447 - $8,207
32 Added 4.75%
705 $173,000
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $9,306 - $10,183
40 Added 6.32%
673 $164,000
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $126,721 - $140,256
-546 Reduced 46.31%
633 $154,000
Q4 2020

Feb 10, 2021

SELL
$221.92 - $245.94 $34,397 - $38,120
-155 Reduced 11.62%
1,179 $295,000
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $80,913 - $103,785
-375 Reduced 21.94%
1,334 $310,000
Q2 2020

Aug 11, 2020

BUY
$219.9 - $263.41 $71,027 - $85,081
323 Added 23.3%
1,709 $409,000
Q1 2020

May 12, 2020

SELL
$195.69 - $279.01 $1.18 Million - $1.68 Million
-6,012 Reduced 81.27%
1,386 $318,000
Q4 2019

Feb 11, 2020

BUY
$236.45 - $266.82 $65,969 - $74,442
279 Added 3.92%
7,398 $2.01 Million
Q3 2019

Nov 13, 2019

BUY
$230.58 - $256.08 $1.56 Million - $1.73 Million
6,775 Added 1969.48%
7,119 $1.8 Million
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $652 - $738
-3 Reduced 0.86%
344 $87,000
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $22,253 - $26,802
-108 Reduced 23.74%
347 $87,000
Q4 2018

Feb 13, 2019

SELL
$204.73 - $257.93 $10,236 - $12,896
-50 Reduced 9.9%
455 $103,000
Q3 2018

Nov 13, 2018

SELL
$233.07 - $256.0 $2,563 - $2,816
-11 Reduced 2.13%
505 $132,000
Q2 2018

Aug 01, 2018

SELL
$208.1 - $233.85 $11,029 - $12,394
-53 Reduced 9.31%
516 $124,000
Q1 2018

May 16, 2018

SELL
$205.46 - $240.27 $6.2 Million - $7.26 Million
-30,200 Reduced 98.15%
569 $123,000
Q4 2017

Feb 13, 2018

BUY
$189.0 - $222.64 $5.7 Million - $6.71 Million
30,153 Added 4894.97%
30,769 $6.59 Million
Q3 2017

Nov 08, 2017

BUY
$186.89 - $198.9 $7,101 - $7,558
38 Added 6.57%
616 $121,000
Q2 2017

Aug 15, 2017

SELL
N/A
-137 Reduced 19.16%
578 $113,000
Q1 2017

Sep 15, 2017

SELL
N/A
-32 Reduced 4.28%
715 $131,000
Q4 2016

Sep 15, 2017

BUY
N/A
6 Added 0.81%
747 $124,000
Q3 2016

Sep 15, 2017

BUY
N/A
184 Added 33.03%
741 $133,000
Q2 2016

Sep 15, 2017

SELL
N/A
-132 Reduced 19.16%
557 $94,000
Q1 2016

Sep 15, 2017

BUY
N/A
25 Added 3.77%
689 $105,000
Q4 2015

Sep 15, 2017

BUY
N/A
664
664 $102,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.